The mission of the committee will be to ensure The Emerald Conference provides the most cutting-edge technical-scientific content that will provoke collaboration and the advancement of science in the cannabis industry.
Iniobong Afia, Ph.D.
Chief Science Officer, CannaSafe
Chief Science Officer, Veda Scientific
Director of Bioinformatics, Steep Hill Labs
Senior Applications Scientist, SPEX, an Antylia Scientific Company
Toby Astill, Ph.D.
Global Market Manager for Cannabis & Hemp, PerkinElmer
Robert D. Brodnick, Ph.D.
Chief Executive Officer, Titan Analytical
David Dawson, Ph.D.
Senior Scientist, Via Innovations
Brad Douglass, Ph.D.
VP Regulatory Affairs, The Werc Shop
Chief Scientific Officer, Eighth Revolution
Kelly N. Greenland, Ph.D
Owner & Chief Scientific Officer, Keystone State Testing, LLC
Chris Hudalla, Ph.D.
President & Chief Scientific Officer, ProVerde Laboratories, Inc.
Hope Jones, Ph.D.
Chief Executive Officer, Emergent Cannabis Sciences
Ben Katchman, Ph.D.
VP, Research & Development, PathogenDx
Jack Lamont, MS
Assistant Cultivation Manager, Ascend Wellness Holdings
Catharine E. Layton
Principal Scientist, Waters Corporation
Director of Operations, Apoteka
Chief Executive Officer, Orion GMP Solutions
Sr Scientist Strategic Services, PharmaCann
VP of Regulatory Compliance & Quality, Phase4Services
Jean Talleyrand, M.D.
Chief Medical Officer, Clinical Endocannabinoid System Consortium (CESC) Inc.
Regulatory Compliance Specialist, Cannabis Consulting
Marian Twohig, Ph.D.
Consultant Scientist, Waters Corporation
Scot Waring, Ph.D.